Search is not available for this dataset
name
string | tag
string | uom
string | ddate
int64 | report
int64 | line
int64 | value
string | adsh
string | stmt
string | form
string | fy
int64 | fye
int64 | fp
string | url
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIO-EN HOLDINGS CORP.
|
AdditionalPaidInCapital
|
USD
| 20,191,231
| 2
| 16
|
352,681
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
RetainedEarningsAccumulatedDeficit
|
USD
| 20,181,231
| 2
| 17
|
-421,991
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
RetainedEarningsAccumulatedDeficit
|
USD
| 20,191,231
| 2
| 17
|
-548,147
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
StockholdersEquity
|
USD
| 20,171,231
| 2
| 18
|
-209,440
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
StockholdersEquity
|
USD
| 20,181,231
| 2
| 18
|
-61,575
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
StockholdersEquity
|
USD
| 20,191,231
| 2
| 18
|
-187,731
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
LiabilitiesAndStockholdersEquity
|
USD
| 20,181,231
| 2
| 19
|
11,640
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
LiabilitiesAndStockholdersEquity
|
USD
| 20,191,231
| 2
| 19
|
241,524
|
0001104659-20-061458
|
BS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetIncomeLoss
|
USD
| 20,181,231
| 6
| 2
|
-88,385
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetIncomeLoss
|
USD
| 20,191,231
| 6
| 2
|
-126,156
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
USD
| 20,181,231
| 6
| 5
|
-102,130
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
USD
| 20,191,231
| 6
| 5
|
11,598
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsReceivable
|
USD
| 20,181,231
| 6
| 6
|
-6,220
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsReceivable
|
USD
| 20,191,231
| 6
| 6
|
-234,884
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInOperatingActivities
|
USD
| 20,181,231
| 6
| 7
|
-196,735
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInOperatingActivities
|
USD
| 20,191,231
| 6
| 7
|
-349,442
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
ProceedsFromIssuanceOfCommonStock
|
USD
| 20,181,231
| 6
| 9
|
236,250
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
ProceedsFromRepaymentsOfRelatedPartyDebt
|
USD
| 20,181,231
| 6
| 12
|
-34,155
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
ProceedsFromRepaymentsOfRelatedPartyDebt
|
USD
| 20,191,231
| 6
| 12
|
344,442
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInFinancingActivities
|
USD
| 20,181,231
| 6
| 13
|
-34,155
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInFinancingActivities
|
USD
| 20,191,231
| 6
| 13
|
344,442
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD
| 20,181,231
| 6
| 14
|
5,360
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD
| 20,191,231
| 6
| 14
|
-5,000
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD
| 20,171,231
| 6
| 16
|
60
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD
| 20,181,231
| 6
| 16
|
5,420
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD
| 20,191,231
| 6
| 16
|
420
|
0001104659-20-061458
|
CF
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
MarketingAndAdvertisingExpense
|
USD
| 20,191,231
| 4
| 4
|
9,607
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
ConsultingExpenses
|
USD
| 20,191,231
| 4
| 5
|
9,440
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
OfficeSuppliesAndTravel
|
USD
| 20,191,231
| 4
| 6
|
1,474
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
FilingFees
|
USD
| 20,181,231
| 4
| 8
|
21,053
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
FilingFees
|
USD
| 20,191,231
| 4
| 8
|
13,428
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
SecretarialExpenses
|
USD
| 20,181,231
| 4
| 9
|
9,614
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
SecretarialExpenses
|
USD
| 20,191,231
| 4
| 9
|
7,035
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
OtherGeneralExpense
|
USD
| 20,181,231
| 4
| 10
|
239
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
OtherGeneralExpense
|
USD
| 20,191,231
| 4
| 10
|
450
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
AccountingFees
|
USD
| 20,181,231
| 4
| 12
|
24,000
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
AccountingFees
|
USD
| 20,191,231
| 4
| 12
|
24,000
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
AuditingFees
|
USD
| 20,181,231
| 4
| 13
|
29,000
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
AuditingFees
|
USD
| 20,191,231
| 4
| 13
|
42,000
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
LegalFees
|
USD
| 20,181,231
| 4
| 14
|
4,479
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
LegalFees
|
USD
| 20,191,231
| 4
| 14
|
18,722
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
OperatingIncomeLoss
|
USD
| 20,181,231
| 4
| 15
|
88,385
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
OperatingIncomeLoss
|
USD
| 20,191,231
| 4
| 15
|
126,156
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetIncomeLoss
|
USD
| 20,181,231
| 4
| 17
|
-88,385
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
NetIncomeLoss
|
USD
| 20,191,231
| 4
| 17
|
-126,156
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
shares
| 20,181,231
| 4
| 20
|
77,350,003
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
shares
| 20,191,231
| 4
| 20
|
77,350,003
|
0001104659-20-061458
|
IS
|
10-K
| 2,019
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html
|
BIO-EN HOLDINGS CORP.
|
CashAndCashEquivalentsAtCarryingValue
|
USD
| 20,191,231
| 2
| 3
|
420
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CashAndCashEquivalentsAtCarryingValue
|
USD
| 20,201,231
| 2
| 3
|
11,710
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AccountsReceivableNetCurrent
|
USD
| 20,191,231
| 2
| 4
|
241,104
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AccountsReceivableNetCurrent
|
USD
| 20,201,231
| 2
| 4
|
15,000
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AssetsCurrent
|
USD
| 20,191,231
| 2
| 5
|
241,524
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AssetsCurrent
|
USD
| 20,201,231
| 2
| 5
|
26,710
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
Assets
|
USD
| 20,191,231
| 2
| 6
|
241,524
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
Assets
|
USD
| 20,201,231
| 2
| 6
|
26,710
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AccountsPayableAndAccruedLiabilitiesCurrent
|
USD
| 20,191,231
| 2
| 9
|
48,968
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AccountsPayableAndAccruedLiabilitiesCurrent
|
USD
| 20,201,231
| 2
| 9
|
93,238
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NotesPayableRelatedPartiesClassifiedCurrent
|
USD
| 20,191,231
| 2
| 10
|
380,287
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NotesPayableRelatedPartiesClassifiedCurrent
|
USD
| 20,201,231
| 2
| 10
|
376,250
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
LiabilitiesCurrent
|
USD
| 20,191,231
| 2
| 11
|
429,255
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
LiabilitiesCurrent
|
USD
| 20,201,231
| 2
| 11
|
469,488
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
Liabilities
|
USD
| 20,191,231
| 2
| 12
|
429,255
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
Liabilities
|
USD
| 20,201,231
| 2
| 12
|
469,488
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CommonStockValue
|
USD
| 20,191,231
| 2
| 15
|
7,735
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CommonStockValue
|
USD
| 20,201,231
| 2
| 15
|
7,735
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AdditionalPaidInCapital
|
USD
| 20,191,231
| 2
| 16
|
352,681
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
AdditionalPaidInCapital
|
USD
| 20,201,231
| 2
| 16
|
352,681
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
RetainedEarningsAccumulatedDeficit
|
USD
| 20,191,231
| 2
| 17
|
-548,147
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
RetainedEarningsAccumulatedDeficit
|
USD
| 20,201,231
| 2
| 17
|
-803,194
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
StockholdersEquity
|
USD
| 20,181,231
| 2
| 18
|
-61,575
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
StockholdersEquity
|
USD
| 20,191,231
| 2
| 18
|
-187,731
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
StockholdersEquity
|
USD
| 20,201,231
| 2
| 18
|
-442,778
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
LiabilitiesAndStockholdersEquity
|
USD
| 20,191,231
| 2
| 19
|
241,524
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
LiabilitiesAndStockholdersEquity
|
USD
| 20,201,231
| 2
| 19
|
26,710
|
0001104659-21-049930
|
BS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NetIncomeLoss
|
USD
| 20,191,231
| 6
| 2
|
-126,156
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NetIncomeLoss
|
USD
| 20,201,231
| 6
| 2
|
-255,047
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
USD
| 20,191,231
| 6
| 5
|
11,598
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
USD
| 20,201,231
| 6
| 5
|
44,270
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsReceivable
|
USD
| 20,191,231
| 6
| 6
|
-234,884
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
IncreaseDecreaseInAccountsReceivable
|
USD
| 20,201,231
| 6
| 6
|
226,104
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInOperatingActivities
|
USD
| 20,191,231
| 6
| 7
|
-349,442
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInOperatingActivities
|
USD
| 20,201,231
| 6
| 7
|
15,327
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
ProceedsFromRepaymentsOfRelatedPartyDebt
|
USD
| 20,191,231
| 6
| 9
|
344,442
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
ProceedsFromRepaymentsOfRelatedPartyDebt
|
USD
| 20,201,231
| 6
| 9
|
-4,037
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInFinancingActivities
|
USD
| 20,191,231
| 6
| 10
|
344,442
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
NetCashProvidedByUsedInFinancingActivities
|
USD
| 20,201,231
| 6
| 10
|
-4,037
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD
| 20,191,231
| 6
| 11
|
-5,000
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD
| 20,201,231
| 6
| 11
|
11,290
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD
| 20,181,231
| 6
| 12
|
5,420
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD
| 20,191,231
| 6
| 12
|
420
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD
| 20,201,231
| 6
| 12
|
11,710
|
0001104659-21-049930
|
CF
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
MarketingAndAdvertisingExpense
|
USD
| 20,191,231
| 4
| 4
|
9,607
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
ConsultingExpenses
|
USD
| 20,191,231
| 4
| 5
|
9,440
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
ConsultingExpenses
|
USD
| 20,201,231
| 4
| 5
|
1,657
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
OfficeSuppliesAndTravel
|
USD
| 20,191,231
| 4
| 6
|
1,474
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
OfficeSuppliesAndTravel
|
USD
| 20,201,231
| 4
| 6
|
520
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
FilingFees
|
USD
| 20,191,231
| 4
| 7
|
13,428
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
FilingFees
|
USD
| 20,201,231
| 4
| 7
|
14,106
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
SecretarialExpenses
|
USD
| 20,191,231
| 4
| 8
|
7,035
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
BIO-EN HOLDINGS CORP.
|
SecretarialExpenses
|
USD
| 20,201,231
| 4
| 8
|
1,106
|
0001104659-21-049930
|
IS
|
10-K
| 2,020
| 1,231
|
FY
|
https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.